International Journal of Environmental Research and Public Health,
Journal Year:
2024,
Volume and Issue:
21(8), P. 986 - 986
Published: July 27, 2024
Given
diversified
cannabis
products,
we
examined
associations
between
consumption
methods
and
risk
perception
of
smoking
1–2
times
a
week.
Using
the
2022
U.S.
National
Survey
on
Drug
Use
Health
data
(N
=
12,796
past-year
adult
users;
M
6127
F
6669),
used
multinomial
binary
logistic
regression
models.
Smoking
was
most
prevalent
method,
followed
by
eating/drinking,
vaping,
dabbing.
One-half
users
reported
no
perceived
week,
37.5%
slight
risk,
9.2%
moderate
2.9%
great
risk.
Those
with
or
had
lower
likelihood
using
4+
(e.g.,
RRR
0.40,
95%
CI
0.20,
0.77
for
perception).
Any
associated
higher
odds
edibles/drinks
only
aOR
2.81,
1.43,
5.54
Along
medical
use
CUD,
sociodemographic
factors,
mental
illness,
other
substance
were
also
significant
correlates
methods.
Understanding
varying
perceptions
different
is
needed
harm
reduction
initiatives.
More
research
particularly
dabs/concentrates,
to
better
understand
potential
risks
them.
Addictive Behaviors,
Journal Year:
2025,
Volume and Issue:
unknown, P. 108357 - 108357
Published: April 1, 2025
Localities
have
extended
smoke-free
policies
to
prohibit
use
of
combustible
and
vaping
products
for
nicotine/tobacco
cannabis
(THC),
but
little
is
known
about
how
this
affects
behavior.
We
used
Ecological
Momentary
Assessment
examine
perceived
exposure
smoking-
vaping-specific
prohibitions
nicotine
THC
vaping.
Young
adults
(n
=
178;
age
25;
55
%
male;
47
Hispanic,
21
Asian,
White)
in
California
who
endorsed
past-month
and/or
were
recruited
from
an
existing
longitudinal
study.
In
2023,
individuals
completed
up
five
brief
surveys
each
day
over
days
assess
behavior
momentary
context
(e.g.,
vaping/smoking
prohibitions)
non-use
(random
prompt)
events.
Multilevel
generalized
linear
mixed
models
assessed
associations
between
likelihood
or
(vs.
events).
showed
reduced
(aOR
0.60,
95
CI
0.42
-
0.85;
p
0.004)
0.48,
0.33
0.69;
<
0.0001)
settings
where
smoking
prohibited
compared
which
allowed.
Exposure
only
was
(vaping
allowed)
associated
with
increased
2.13,
1.34
3.39;
0.002),
unrelated
0.87,
0.53
1.44;
0.59).
Efforts
increase
young
people's
awareness
compliance
may
help
reduce
both
real-world
settings.
MMWR Morbidity and Mortality Weekly Report,
Journal Year:
2025,
Volume and Issue:
74(12), P. 198 - 204
Published: April 10, 2025
Access
to
and
use
of
cannabis
in
the
United
States
has
increased
as
new
product
types
emerge
marketplace,
additional
states
legalize
its
for
medical
nonmedical
purposes.
To
tailor
education
messages
preventing
adverse
health
effects
use,
understanding
routes
these
products
general
population
is
important.
The
2022
Behavioral
Risk
Factor
Surveillance
System
included
a
newly
revised
optional
marijuana
module
comprising
questions
on
among
adults
aged
≥18
years
who
used
during
past
30
days
(current
use).
Twenty-two
two
territories
administered
2022.
Weighted
prevalences
(with
95%
CIs)
current
daily
or
near-daily
well
prevalence
each
route
were
reported
overall
by
demographic
characteristics
and,
women
≤49
years,
pregnancy
status.
Among
15.3%
respondents
smoking
was
most
frequent
(79.4%),
followed
eating
(41.6%),
vaping
(30.3%),
dabbing
(inhaling
heated
concentrated
cannabis)
(14.6%).
Vaping
prevalent
persons
18-24
years.
Intervention
measures
intended
smoke
are
important;
however,
outcomes
associated
with
other
might
have
substantial
public
benefit.
JAMA Network Open,
Journal Year:
2025,
Volume and Issue:
8(4), P. e255819 - e255819
Published: April 18, 2025
Importance
A
year
after
dried
cannabis
was
legalized
across
Canada
in
October
2018,
Canadian
provinces
except
Quebec
sales
of
edibles
and
extracts,
including
youth-friendly
such
as
chocolates,
candies,
desserts
vaping
products.
Little
is
known
about
the
association
this
legalization
with
adolescent
use.
Objective
To
investigate
changes
use
harm
perceptions
associated
extracts
Canada.
Design,
Setting,
Participants
This
serial
cross-sectional
study
analyzed
data
from
students
grades
7
to
11
who
participated
nationally
representative
Student
Tobacco
Alcohol
Drugs
Surveys
2018
2019
2021
2022.
differences-in-differences
design
compared
outcomes
that
where
products
were
banned.
Data
June
2024
January
2025.
Exposure
Legalization
(except
Quebec)
2019.
Main
Outcomes
Measures
The
primary
past
12
months,
12-month
edible
use,
smoking,
vaping,
co-use
alcohol
cannabis.
Secondary
perception
occasional
regular
Results
In
sample
106
032
(54
441
male
[weighted
percentage,
51.3%]),
between
2022,
increased
14.6%
(6081
41
477
students)
15.9%
(6163
38
675
7.9%
(3268
373
9.5%
(3678
556
extracts.
Meanwhile,
declined
17.4%
(2264
13
030
15.6%
(1960
550
7.3%
(955
002
5.9%
(739
533
Quebec.
Regression
analyses
indicated
a
3.8
percentage
point
(95%
CI,
1.1
6.6
points;
P
=
.01)
or
26%
increase
3.4
1.9
4.9
.001)
43%
among
adolescents.
While
there
no
statistically
significant
change
legalization,
smoking
by
4.4
points
1.8
7.0
.004)
34%
2.4
0.5
4.3
.02)
28%.
also
lower
Conclusions
Relevance
adolescents
11,
an
not
only
but
overall
prevalence
cannabis,
highlighting
need
for
stricter
policy
measures
curb
adolescents’
access
greater
awareness
harms
Abstract
Background
E-cigarette
use
(i.e.,
vaping)
is
prevalent
among
young
adults
in
the
U.S.
Studies
show
that
who
vape
are
more
likely
to
initiate
cigarette
smoking
than
do
not
vape.
Despite
this,
little
research
on
vaping
interventions
and
prevention
of
for
exist.
Methods
A
2-arm
pilot
randomized
controlled
trial
(RCT)
will
be
conducted
by
recruiting
ages
18–24
reported
at
least
once
per
week
past
30
days
having
never
smoked
cigarettes
baseline.
Participants
recruited
via
social
media
ads
randomly
assigned
an
intervention
arm,
which
Live
Free
From
E-cigarettes
(LIFFE)
mobile-based
program
(
n
=
50),
or
a
waitlist
control
arm
50).
The
primary
outcomes
biochemically
verified
7-day
point
prevalence
abstinence
nicotine
vaping,
reduction,
susceptibility.
Outcomes
measured
2-,
4-,
8-weeks
after
randomization.
Discussion
This
first
RCT
evaluate
effectiveness
targets
susceptibility
while
also
supporting
cessation
reduction
adults.
Findings
may
inform
future
efforts
prevent
transition
Trial
registration
ClinicalTrials.gov:
NCT06129123;
Date
registration:
11/10/2023.
Journal of Cannabis Research,
Journal Year:
2025,
Volume and Issue:
7(1)
Published: May 16, 2025
Following
the
legalization
of
cannabis
in
several
U.S.
states,
market
has
expanded,
leading
to
a
wider
range
products
including
smoked,
edible,
and
vape
which
have
variable
health
effects.
This
proliferation
highlights
need
for
more
research
on
patterns
current
use
among
adults.
We
used
combined
data
adults
who
currently
(i.e.,
past
30-day
use)
(n
=
16,999)
from
2022
2023
National
Survey
Drug
Use
Health.
analyzed
whether
seven
modalities
smoking,
vaping,
dabbing,
consuming
edibles,
taking
pills,
applying
topicals,
absorbing
sublingually/orally
varied
by
age,
sex,
race
ethnicity,
sexual
orientation,
education,
income,
geographic
location,
state
medical
laws
status
generating
weighted
proportion
estimates
conducting
multivariable
logistic
regression.
Additionally,
subanalysis,
we
examined
differences
blunt
reported
12,355),
employing
similar
methods
explore
associations
with
demographic
socioeconomic
factors.
Among
cannabis,
smoking
was
most
common
method
(77.33%),
followed
edibles
(37.31%),
vaping
(34.75%),
dabbing
(15.01%),
topicals
(5.93%),
(4.53%),
pills
(2.11%).
Edibles
were
popular
aged
35-49
years
(29.57%),
whereas
young
18-25
(29.80%).
Females
(vs.
males)
had
lower
odds
(OR:
0.65;
95%
CI:
0.57-0.75)
higher
2.92;
2.23-3.83).
Non-Hispanic
Black
non-Hispanic
White)
respondents
2.03;
1.51-2.74)
0.66;
0.56-0.77).
Adults
50
+
18-25)
greater
2.45;
1.59-3.76).
In
found
that
5.31;
4.23-6.65).
modality
disparities
highlight
tailored
public
education
interventions,
given
distinct
risks
associated
each
use.
Substance Use & Misuse,
Journal Year:
2025,
Volume and Issue:
unknown, P. 1 - 6
Published: May 16, 2025
Local
policies
prohibiting
cannabis
sales
and
lower
retail
availability
are
associated
with
a
prevalence
of
adolescent
use.
In
this
study,
we
examined
whether
local
prohibitions
on
retailer
proximity
density
adverse
cannabis-related
mental
health
outcomes
among
adolescents.
Cross-sectional
study
95,645
Northern
California
adolescents
aged
13-17
who
completed
well-check
questionnaire
in
2021
during
standard
pediatric
care.
Exposures
included
bans
storefront
delivery
retailers,
relation
to
adolescents'
geocoded
residences.
Past-year
psychotic,
depressive,
anxiety
disorders
were
identified
using
ICD
codes;
self-reported
depression
symptoms
came
from
the
questionnaire.
Relative
jurisdictions
allowing
retail,
those
only
(aPR
=
0.52;
95%CI:
0.32-0.85),
or
both
0.67;
0.48-0.92)
had
psychotic
disorders.
Greater
(≥6
vs.
0
retailers
within
15-min
drive)
was
greater
1.11;
1.04-1.19),
depressive
1.10;
1.02-1.19)
1.08;
1.01-1.15).
Having
≥20-min
(vs.
<5-min)
drive
nearest
0.53;
0.33-0.86),
0.89;
0.82-0.97),
0.81-0.98)
0.91;
0.84-0.99).
near
residences
anxiety,
disorders,
symptoms.
Policies
limiting
may
help
reduce
harms
merit
further
assessment.
Addiction,
Journal Year:
2024,
Volume and Issue:
119(9), P. 1502 - 1504
Published: March 7, 2024
Considerable
differences
in
the
types
of
cannabis
products,
methods
use,
social
norms
and
cultures
legal
climates
surrounding
use
exist
among
regions,
resulting
distinct
contexts.
Research
examining
accounting
for
these
contextual
is
crucial
to
further
understanding
disorder,
developing
refining
context
sensitive
strategies
prevention,
treatment
harm
reduction.
The
past
two
decades
have
seen
increased
legalization
recreational
across
globe,
prevalence
emerging
evidence
cannabis-related
harms
[1].
We
argue
that
precisely
how
impacts
people
who
cannabis,
as
well
likely
why,
may
vary
substantially
depending
upon
variation
legislation,
promotion,
acceptability
around
use.
These
factors
create
unique
regionally
specific
'cannabis
contexts'.
Although
broader
cross-cultural
considerations
apply
all
addictions
we
believe
they
are
particularly
important
given
global
changes
towards
more
lenient
policies.
aim
increase
awareness
stimulate
research
debate
regarding
contexts
shape
processes
underlying
disorder
(CUD)
associated
outcomes.
percentage
Δ9-tetrahydrocannabinol
(THC)
products
has
been
increasing
internationally
[1],
but
there
substantial
markets
type
product
Use
higher-potency
appears
risen
United
States
be
common
states
legalized
[2].
temporal
regional
health
implications
[3].
Further
individual
cannabinoid
exposure,
new
THC
rising
popularity
US
market,
with
one
six
users
reporting
Δ8-THC
[4].
produces
fewer
psychoactive
effects
than
Δ9-THC,
preferred
those
seeking
medicinal
benefit,
indicating
a
potential
difference
attitudes
Common
routes
administration
(ROA)
also
differ
throughout
regions
impact
bioavailability
cannabinoids.
Cannabis
combustion
results
faster
onset
action
higher
blood
levels
relative
oral
ingestion
[5].
While
smoking
still
most
prevalent
ROA
Canada,
edible
[6]
smoked
flower
combined
tobacco
European
countries
[7].
Nicotine
cannabinoids
compensatory
synergistic
neurobiological
[8],
nicotine–cannabis
co-users
severe
CUD
prognoses
[9].
variations
result
differential
frequent
on
other
physical,
cognitive
mental
policies,
perceived
it,
influence
trajectories
probably
contribute
CUD.
More
permissive
community
heightened
[10].
interplay
policies
feed
into
interact
perceptions
one's
own
producing
different
outcomes
In
States,
availability
declining
parallel
rates
[11].
Despite
such
increases
self-reported
[12].
Some
that,
rather
reflecting
legitimate
decline
CUD,
this
seemingly
contradictory
pattern
reflect
reduced
treatment-seeking
some
(e.g.
[13]).
tentatively
agree:
per
se,
concomitant
drug
then
acquired,
can
alter
drug's
safety,
turn
potentially
changing
consequences
[14].
Such
forms
messaging
cannabis—for
example,
presence
signs
promoting
benefits
dispensaries
California
[15].
emergence
evidence-based
purported
therapeutic
appeal
bring
while
already
cannabis.
contrast
Canadian
reported
risk
post-legalization
[16],
preliminary
data
from
emergency
psychiatric
units
indicate
[17].
entry
Europe
[18].
short,
local
social,
regulatory
societal
milieu
which
consumed
exceedingly
complex.
There
reasons
affect
initiates
it
affects
them
whether
perceive
effects.
Greater
attention
improve
our
If
experiences
are—as
suggest—potentially
so
variable,
proceed
investigating
cannabis?
One
approach
sample
niche
populations
homogeneous,
cannabis-only
users,
will
ignore
reality
It
complex
picture
need
understand
provide
nuanced
guidelines
safer
patterns
generalize
wider
population
Instead,
researchers
should
embrace
heterogeneity
study
context.
To
achieve
this,
recommend
following;
first,
urge
report
standardized
fashion.
iCannToolkit
[19]
framework
facilitating
integration
characterization
context-specific
proposes
time-line
follow-back
(TLFB)
methodology
(in
combination
5-mg
unit
ROA)
an
extensive
self-report
quantification
method.
Self-reports
quick
reliable
proxy
exposure
[20].
Secondly,
when
testing
time
allows
risks
motives
versus
medicinal)
relevant
incorporate.
When
samples
large
enough,
exploratory
analyses
assess
Beyond
studying
valuable
public
regions—including
often
under-represented
minority
groups—over
time.
Finally,
strongly
studies
incorporate
explicit
context'
statements,
including
elements
described
Box
1.
statements
brief
overview
typical
was
conducted
help
characterize
studies,
improving
synthesis.
Over
time,
information
contained
even
used
meta-analytically
explain
findings
regions.
Location
Year
policy
(i.e.
status
and/or
commercial
non-commercial)
Description
retail
market
(if
applicable)
method
Average
content
available)
Regional
Janna
Cousijn:
Conceptualization
(equal);
funding
acquisition
supervision
(lead);
writing—original
draft
(supporting);
writing—review
editing
(lead).
Lauren
Kuhns:
(equal).
Francesca
Filbey:
(supporting).
Tom
P.
Freeman:
Emese
Kroon:
This
supported
by
grant
1R01
DA042490-01A1
awarded
Cousijn
Filbey
National
Institute
Drug
Abuse/National
Health.
All
authors
no
conflicts
interest
declare.
The American Journal of Drug and Alcohol Abuse,
Journal Year:
2024,
Volume and Issue:
50(4), P. 557 - 565
Published: July 3, 2024
Despite
an
increase
in
the
varieties
of
cannabis
products
available
for
consumption,
limited
evidence
is
about
patterns
consumption
methods
before
and
after
legalization.
Research Square (Research Square),
Journal Year:
2025,
Volume and Issue:
unknown
Published: April 2, 2025
Purpose:
Following
the
legalization
of
cannabis
in
several
U.S.
states,
market
has
expanded,
leading
to
a
wider
range
products
including
smoked,
edible,
and
vape
which
have
variable
health
effects.
This
proliferation
highlights
need
for
more
research
on
patterns
current
use
among
adults.
Methods:
We
used
combined
data
adults
who
currently
(i.e.,
past
30-day
use)
(n=16,999)
from
2022
2023
National
Survey
Drug
Use
Health.
analyzed
whether
seven
modalities
smoking,
vaping,
dabbing,
consuming
edibles,
taking
pills,
applying
topicals,
absorbing
sublingually/orally
varied
by
age,
sex,
race
ethnicity,
sexual
orientation,
education,
income,
geographic
location,
state
medical
laws
status
generating
weighted
proportion
estimates
conducting
multivariable
logistic
regression.
Additionally,
subanalysis,
we
examined
differences
blunt
reported
(n=12,355),
employing
similar
methods
explore
associations
with
demographic
socioeconomic
factors.
Results:
Among
cannabis,
smoking
was
most
common
method
(77.33%),
followed
edibles
(37.31%),
vaping
(34.75%),
dabbing
(15.01%),
topicals
(5.93%),
(4.53%),
pills
(2.11%).
Edibles
were
popular
aged
35-49
years
(29.57%),
whereas
young
18-25
(29.80%).
Females
(vs.
males)
had
lower
odds
(OR:
0.65;
95%
CI:
0.57-0.75)
higher
2.92;
2.23-3.83).
Non-Hispanic
Black
non-Hispanic
White)
respondents
2.03;
1.51-2.74)
0.66;
0.56-0.77).
Adults
50+
18-25)
greater
2.45;
1.59-3.76).
In
found
that
5.31;
4.23-6.65).
Conclusions:
modality
disparities
highlight
tailored
public
education
interventions,
given
distinct
risks
associated
each
use.